Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Andreas V. Madsen, Peter Kristensen, Alexander K. Buell & Steffen Goletz. (2023) Generation of robust bispecific antibodies through fusion of single-domain antibodies on IgG scaffolds: a comprehensive comparison of formats. mAbs 15:1.
Read now
Read now
Lennart Kühl, Annelie K. Schäfer, Sebastian Kraft, Nadine Aschmoneit, Roland E. Kontermann & Oliver Seifert. (2023) eIg-based bispecific T-cell engagers targeting EGFR: Format matters. mAbs 15:1.
Read now
Read now
Jie Zhao, Liangfeng Jiang, Haodong Yang, Lan Deng, Xiaoqing Meng, Jian Ding, Sixing Yang, Le Zhao, Wei Xu, Xiaolong Wang, Zhenping Zhu & Haomin Huang. (2022) A strategy for the efficient construction of anti-PD1-based bispecific antibodies with desired IgG-like properties. mAbs 14:1.
Read now
Read now
Haitao Pan, Jiayu Liu, Wentong Deng, Jieyu Xing, Qing Li & Zhong Wang. (2018) Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy. International Journal of Nanomedicine 13, pages 3189-3201.
Read now
Read now
Heather A. Cooke, Joe Arndt, Chao Quan, Renée I. Shapiro, Dingyi Wen, Susan Foley, Malgorzata M. Vecchi & Martin Preyer. (2018) EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies. mAbs 10:8, pages 1248-1259.
Read now
Read now
Shiyong Gong, Fang Ren, Danqing Wu, Xuan Wu & Chengbin Wu. (2017) Fabs-in-tandem immunoglobulin is a novel and versatile bispecific design for engaging multiple therapeutic targets. mAbs 9:7, pages 1118-1128.
Read now
Read now
Ulrich Brinkmann & Roland E. Kontermann. (2017) The making of bispecific antibodies. mAbs 9:2, pages 182-212.
Read now
Read now
Christian Klein, Wolfgang Schaefer & Jörg T. Regula. (2016) The use of CrossMAb technology for the generation of bi- and multispecific antibodies. mAbs 8:6, pages 1010-1020.
Read now
Read now
Articles from other publishers (41)
Daniel Keri, Matt Walker, Isha Singh, Kyle Nishikawa & Fernando Garces. (2023) Next generation of multispecific antibody engineering. Antibody Therapeutics.
Crossref
Crossref
Xiaohan Guo, Yi Wu, Ying Xue, Na Xie & Guobo Shen. (2023) Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment. Frontiers in Immunology 14.
Crossref
Crossref
Yanze Sun, Xinmiao Yu, Xiao Wang, Kai Yuan, Gefei Wang, Lingrong Hu, Guoyu Zhang, Wenli Pei, Liping Wang, Chengliang Sun & Peng Yang. (2023) Bispecific antibodies in cancer therapy: Target selection and regulatory requirements. Acta Pharmaceutica Sinica B.
Crossref
Crossref
Filippo Benedetti, Gerhard Stadlmayr, Katharina Stadlbauer, Florian Rüker & Gordana Wozniak-Knopp. 2023. Genotype Phenotype Coupling. Genotype Phenotype Coupling
131
159
.
Cheng Zhang & Paul Anthony Dalby. 2023. Computer-Aided Antibody Design. Computer-Aided Antibody Design
165
197
.
Moffat M. Malisheni, Matthew Bates, Albert A. Rizvanov & Paul A. MacAry. (2022) SARS-CoV-2 Antibody Effectiveness Is Influenced by Non-Epitope Mutation/Binding-Induced Denaturation of the Epitope 3D Architecture. Pathogens 11:12, pages 1437.
Crossref
Crossref
Agata Kowalik, Mateusz Majerek, Krzysztof Mrowiec, Joanna Solich, Agata Faron-Górecka, Olga Woźnicka, Marta Dziedzicka-Wasylewska & Sylwia Łukasiewicz. (2022) Dopamine D2 and Serotonin 5-HT1A Dimeric Receptor-Binding Monomeric Antibody scFv as a Potential Ligand for Carrying Drugs Targeting Selected Areas of the Brain. Biomolecules 12:6, pages 749.
Crossref
Crossref
Karen J Froning, Arlene Sereno, Flora Huang & Stephen J Demarest. (2022) Generalizable design parameters for soluble T cell receptor-based T cell engagers. Journal for ImmunoTherapy of Cancer 10:3, pages e004281.
Crossref
Crossref
Lin Yu, Nan Huang, Liangpeng Ge, Heng Sun, Yuna Fu, Chundong Liu & Jianhua Wang. (2021) Structural design of tetravalent T-cell engaging bispecific antibodies: improve developability by engineering disulfide bonds. Journal of Biological Engineering 15:1.
Crossref
Crossref
Oladapo Olaleye, Natalia Govorukhina, Nico C. van de Merbel & Rainer Bischoff. (2021) Non-Antibody-Based Binders for the Enrichment of Proteins for Analysis by Mass Spectrometry. Biomolecules 11:12, pages 1791.
Crossref
Crossref
Mathilde Poussin, Arlene Sereno, Xiufeng Wu, Flora Huang, Jason Manro, Shanshan Cao, Carmine Carpenito, Andrew Glasebrook, Daniel J Powell Jr & Stephen J Demarest. (2021) Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies. Journal for ImmunoTherapy of Cancer 9:7, pages e002444.
Crossref
Crossref
Jan P. Bogen, Stefania C. Carrara, David Fiebig, Julius Grzeschik, Björn Hock & Harald Kolmar. (2021) Design of a Trispecific Checkpoint Inhibitor and Natural Killer Cell Engager Based on a 2 + 1 Common Light Chain Antibody Architecture. Frontiers in Immunology 12.
Crossref
Crossref
Jiabing Ma, Yicheng Mo, Menglin Tang, Junjie Shen, Yanan Qi, Wenxu Zhao, Yi Huang, Yanmin Xu & Cheng Qian. (2021) Bispecific Antibodies: From Research to Clinical Application. Frontiers in Immunology 12.
Crossref
Crossref
Lin Yu, Nan Huang, Heng Sun, Xi Yang, Yuna Fu, Qiaoli Lang, Jianhua Wang & Liangpeng Ge. (2021) Development of a Tetravalent T-Cell Engaging Bispecific Antibody Against Glypican-3 for Hepatocellular Carcinoma. Journal of Immunotherapy 44:3, pages 106-113.
Crossref
Crossref
Wentao ChenKurt Yun MouPaige SolomonRahul Aggarwal, Kevin K. Leung & James A. Wells. (2021) Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy. Proceedings of the National Academy of Sciences 118:4.
Crossref
Crossref
Manali S. Sawant, Craig N. Streu, Lina Wu & Peter M. Tessier. (2020) Toward Drug-Like Multispecific Antibodies by Design. International Journal of Molecular Sciences 21:20, pages 7496.
Crossref
Crossref
Sun-Il Kwon. (2020) Current Status of the Research and Development of Bispecific Antibodies. Biomedical Science Letters 26:3, pages 136-148.
Crossref
Crossref
Bhawana Shrestha, Alison Schaefer, Elizabeth C. Chavez, Alexander J. Kopp, Timothy M. Jacobs, Thomas R. Moench & Samuel K. Lai. (2020) Engineering tetravalent IgGs with enhanced agglutination potencies for trapping vigorously motile sperm in mucin matrix. Acta Biomaterialia.
Crossref
Crossref
Sung In Lim. (2020) Fine-tuning bispecific therapeutics. Pharmacology & Therapeutics 212, pages 107582.
Crossref
Crossref
Karen Froning, Jack Maguire, Arlene Sereno, Flora Huang, Shawn Chang, Kenneth Weichert, Anton J. Frommelt, Jessica Dong, Xiufeng Wu, Heather Austin, Elaine M. Conner, Jonathan R. Fitchett, Aik Roy Heng, Deepa Balasubramaniam, Mark T. Hilgers, Brian Kuhlman & Stephen J. Demarest. (2020) Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics. Nature Communications 11:1.
Crossref
Crossref
Qin Xiao & Chunxia Xu. (2020) Research progress on chemiluminescence immunoassay combined with novel technologies. TrAC Trends in Analytical Chemistry 124, pages 115780.
Crossref
Crossref
Dennis R. Goulet & William M. Atkins. (2020) Considerations for the Design of Antibody-Based Therapeutics. Journal of Pharmaceutical Sciences 109:1, pages 74-103.
Crossref
Crossref
Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov & Gary L. Gilliland. (2019) Antibody Structure and Function: The Basis for Engineering Therapeutics. Antibodies 8:4, pages 55.
Crossref
Crossref
Johan M. S. van der Schoot, Felix L. Fennemann, Michael ValenteYusuf Dolen, Iris M. Hagemans, Anouk M. D. Becker, Camille M. Le GallDuco van Dalen, Alper Cevirgel, Jaco A. C. van BruggenMelanie Engelfriet, Tomislav Caval, Arthur E. H. Bentlage, Marieke F. Fransen, Maaike NederendJeanette H. W. Leusen, Albert J. R. Heck, Gestur Vidarsson, Carl G. FigdorMartijn Verdoes & Ferenc A. Scheeren. (2019) Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering. Science Advances 5:8.
Crossref
Crossref
Justin T. Huckaby, Christina L. Parker, Tim M. Jacobs, Alison Schaefer, Daniel Wadsworth, Alexander Nguyen, Anting Wang, Jay Newby & Samuel K. Lai. (2019) Engineering Polymer‐Binding Bispecific Antibodies for Enhanced Pretargeted Delivery of Nanoparticles to Mucus‐Covered Epithelium. Angewandte Chemie International Edition 58:17, pages 5604-5608.
Crossref
Crossref
Justin T. Huckaby, Christina L. Parker, Tim M. Jacobs, Alison Schaefer, Daniel Wadsworth, Alexander Nguyen, Anting Wang, Jay Newby & Samuel K. Lai. (2019) Engineering Polymer‐Binding Bispecific Antibodies for Enhanced Pretargeted Delivery of Nanoparticles to Mucus‐Covered Epithelium. Angewandte Chemie 131:17, pages 5660-5664.
Crossref
Crossref
Xiufeng Wu & Stephen J. Demarest. (2019) Building blocks for bispecific and trispecific antibodies. Methods 154, pages 3-9.
Crossref
Crossref
Fuyuan Zhang, Bing Liu, Yan Zhang, Junping Wang, Yang Lu, Juan Deng & Shuo Wang. (2019) Application of CdTe/CdS/ZnS quantum dot in immunoassay for aflatoxin B1 and molecular modeling of antibody recognition. Analytica Chimica Acta 1047, pages 139-149.
Crossref
Crossref
Bushra Husain & Diego Ellerman. (2018) Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies. BioDrugs 32:5, pages 441-464.
Crossref
Crossref
Xiufeng Wu, Richard Yuan, Michael Bacica & Stephen J Demarest. (2018) Generation of orthogonal Fab-based trispecific antibody formats. Protein Engineering, Design and Selection 31:7-8, pages 249-256.
Crossref
Crossref
Zi-Jian Chen, Xuan Zhang, Bing-Feng Wang, Mei-Fang Rao, Hong Wang, Hong-Tao Lei, Hui Liu, Yan Zhang, Yuan-Ming Sun & Zhen-Lin Xu. (2018) Production of Antigen-Binding Fragment against O,O-Diethyl Organophosphorus Pesticides and Molecular Dynamics Simulations of Antibody Recognition. International Journal of Molecular Sciences 19:5, pages 1381.
Crossref
Crossref
Zhiheng Wang, Yan Li, Wenbin Liang, Junsong Zheng, Shuhui Li, Chuanmin Hu & An Chen. (2018) A Highly Sensitive Detection System based on Proximity-dependent Hybridization with Computer-aided Affinity Maturation of a scFv Antibody. Scientific Reports 8:1.
Crossref
Crossref
Petra Verdino, Shane Atwell & Stephen J Demarest. (2018) Emerging trends in bispecific antibody and scaffold protein therapeutics. Current Opinion in Chemical Engineering 19, pages 107-123.
Crossref
Crossref
Z. Wu & N.V. Cheung. (2018) T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics. Pharmacology & Therapeutics 182, pages 161-175.
Crossref
Crossref
Juanjuan Du, Yu Cao, Yan Liu, Ying Wang, Yong Zhang, Guangsen Fu, Yuhan Zhang, Lucy Lu, Xiaozhou Luo, Chan Hyuk Kim, Peter G. Schultz & Feng Wang. (2017) Engineering Bifunctional Antibodies with Constant Region Fusion Architectures. Journal of the American Chemical Society 139:51, pages 18607-18615.
Crossref
Crossref
Jijie Gu, Andrew McCluskey & Tariq Ghayur. 2017. Protein Therapeutics. Protein Therapeutics
229
270
.
K. J. Froning, A. Leaver‐Fay, X. Wu, S. Phan, L. Gao, F. Huang, A. Pustilnik, M. Bacica, K. Houlihan, Q. Chai, J. R. Fitchett, J. Hendle, B. Kuhlman & S. J. Demarest. (2017) Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies. Protein Science 26:10, pages 2021-2038.
Crossref
Crossref
Bernhard Knapp, James Dunbar, Marta Alcala & Charlotte M. Deane. (2017) Variable Regions of Antibodies and T-Cell Receptors May Not Be Sufficient in Molecular Simulations Investigating Binding. Journal of Chemical Theory and Computation 13:7, pages 3097-3105.
Crossref
Crossref
Ji-Hee Ha, Jung-Eun Kim & Yong-Sung Kim. (2016) Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins. Frontiers in Immunology 7.
Crossref
Crossref
Mark L Chiu & Gary L Gilliland. (2016) Engineering antibody therapeutics. Current Opinion in Structural Biology 38, pages 163-173.
Crossref
Crossref
Diego Moricoli, Damiano Cosimo Carbonella, Sabrina Dominici, Valentina Fiori, Maria Cristina Balducci, Clara Guerzoni, Maria Cristina Manara, Michela Pasello, Maria Elena Laguardia, Maurizio Cianfriglia, Katia Scotlandi & Mauro Magnani. (2015) Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing’s sarcoma. Applied Microbiology and Biotechnology 100:9, pages 3949-3963.
Crossref
Crossref